Tokyo, Japan

Gakuzo Tamura

This inventor holds 6 USPTO granted patents. Top assignees: Chugai Seiyaku Kabushiki Kaisha, Kyowa Hakko Kogyo Co., Ltd., Meiji Seika Kaisha, Ltd.. Active years: 1979-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gakuzo Tamura. Retrieved from https://idiyas.com/inventor/gakuzo-tamura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 83.3

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1979-2003

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Gakuzo Tamura: Innovator in Pharmaceutical Chemistry

Introduction

Gakuzo Tamura is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of ligands for nuclear receptors. With a total of 6 patents, his work has the potential to impact various medical conditions.

Latest Patents

One of Tamura's latest patents involves the discovery of ligands of the nuclear receptor. It has been newly found that ascochlorin, a known fat-soluble antibiotic, and its homologues serve as ligands for the retinoid X receptor. These compounds react in vivo with the amino group of serum protein to form Schiff bases without exhibiting the side effects associated with retinoids. Ascochlorin and its homologues can be utilized in treating or preventing diseases that can be alleviated by retinoid X receptor ligand-dependent gene transcriptional regulation. This includes conditions such as insulin resistance, hypertension, cerebrovascular diseases, rheumatoid arthritis, autoimmune diseases, calcium metabolic disorders, complications of diabetes, and arteriosclerosis. Furthermore, these compounds can inhibit the denaturation and necrosis of pancreatic Langerhans islet β-cells, thereby supporting insulin productivity.

Another notable patent focuses on pyridyl carbonyl ascochlorin derivatives and their pharmaceutical compositions. These derivatives are designed to treat diabetes, improve lipid metabolism, and control tumors. The versatility of these compounds highlights Tamura's innovative approach to addressing complex health issues.

Career Highlights

Throughout his career, Gakuzo Tamura has worked with notable companies such as Chugai Pharmaceutical Co., Ltd. and Kyowa Hakko Kogyo Co., Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Tamura has collaborated with esteemed colleagues, including Kunio Ando and Tomoyoshi Hosokawa. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Gakuzo Tamura's innovative work in pharmaceutical chemistry, particularly in the area of nuclear receptor ligands, showcases his dedication to improving medical treatments. His contributions have the potential to significantly impact the management of various diseases, making him a noteworthy figure in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…